Skip to content

How the low intensity resistance exercise training affect strength and endurance in patients with organophosphate induced delayed polyneuropathy

Efficacy of low intensity resistance exercise training on strength and endurance in patients with organophosphate induced delayed polyneuropathy - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091019
Enrollment
60
Registered
2025-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticides

Interventions

Intervention1: Low Intensity Resistance Exercises: Low intensity aerobic exercises. It is a part of Organophosphate Induced Delayed Neuropathy Rehabilitation Protocol. Combination of Aerobic exercises

Sponsors

VENKATESAN K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who undergone Intensive Care Unit admission following OPC poisoning Patients developed OPIDPN within 3 months. Patients with lower limb muscle power MRC GREATER THAN 3 Patients with adequate standing balance Patients with adequate interpersonal communication Patients concerning the exercise program

Exclusion criteria

Exclusion criteria: Patients who had recurrent incidence of OPC poisoning and other poisoning Patients with chronic co-morbidities like HTN, DM, hormonal diseases, bronchial asthma Patients who were on mechanical ventilator more than 5 days Patient with previous history of neuromuscular diseases Patients with locomotor disabilities Patients who have precious history of Cardiac Disease Patients with diabetic polyneuropathy, Hepatitis B infection, autoimmune disorders, HIV, kidney disease, liver diseases

Design outcomes

Primary

MeasureTime frame
Level of Endurance on 6 Minute walk test, strength on MRC grading and level of muscle activity with CPKTimepoint: At baseline (beginning) and end of the 4th week.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactVENKATESAN K

MEENAKSHI ACADEMY OF HIGHER EDUCATION AND RESERCH, CHENNAI

hari@maherfpt.ac.in9444840543

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026